Trial Profile
Clinical Trials Insight: 700005581
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2005
Price :
$35
*
At a glance
- Drugs Raseglurant (Primary)
- Indications Anxiety disorders; Migraine
- Focus Adverse reactions; Pharmacokinetics
- 21 Oct 2005 New trial record.